Log in to save to my catalogue

Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes o...

Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2170047

Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer’s disease

About this item

Full title

Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer’s disease

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal of neurology, neurosurgery and psychiatry, 1998-04, Vol.64 (4), p.548-551

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BACKGROUND A genetic association between the presenilin 1 (PS-1) intronic polymorphism and sporadic Alzheimer’s disease has been a matter of controversy. Recent findings have suggested that the PS-1 polymorphism is not associated with Alzheimer’s disease or amyloid β-protein (Aβ) deposition in brains from patients with Alzheimer’s disease. OBJECTIV...

Alternative Titles

Full title

Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2170047

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2170047

Other Identifiers

ISSN

0022-3050

E-ISSN

1468-330X

DOI

10.1136/jnnp.64.4.548

How to access this item